Cleveland Biolabs, Inc. (CBLI) Posts Wider than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Research and development: 1.1M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 1.1M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q2 EPS of ($0.14), $0.10 worse than the analyst estimate of ($0.04).
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
- Legence Corp. (LGN) Misses Q2 EPS by 58c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
